Home > Boards > US Listed > Medical - Equipment >

Cytosorbents Corporation (CTSO)

CTSO RSS Feed 		Add CTSO Price Alert      Hide Sticky   Hide Intro
Moderator: orangecat, dr_lowenstein
Search This Board: 
Last Post: 10/21/2019 8:45:35 PM - Followers: 218 - Board type: Free - Posts Today: 0

CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 45 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the "cytokine storm" or "cytokine release syndrome" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. CytoSorbents recently initiated its pivotal REFRESH (REduction in FREe Hemoglobin) 2 trial – a multi-center, randomized controlled, clinical trial intended to support U.S. regulatory approval of CytoSorb for use in a heart-lung machine during complex cardiac surgery to reduce organ injury. CytoSorb® has been used in more than 46,000 human treatments to date. 

CytoSorbents' purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding of nearly $22 million from DARPA, the U.S. Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM) and others. The Company has numerous products under development based upon this unique blood purification technology, protected by 32 issued U.S. patents and multiple applications pending, including CytoSorb-XL™, HemoDefend™, VetResQ™, K+ontrol™, ContrastSorb, DrugSorb, and others. For more information, please visit the Company's websites at http://www.cytosorbents.com and http://www.cytosorb.com or follow us on Facebook and Twitter.

CTSO
Current Price
Volume:
Bid Ask Day's Range
CTSO Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTSO News: Current Report Filing (8-k) 09/18/2019 04:32:01 PM
CTSO News: Current Report Filing (8-k) 09/16/2019 05:25:15 PM
CTSO News: Securities Registration: Employee Benefit Plan (s-8) 08/26/2019 04:12:55 PM
CTSO News: Statement of Changes in Beneficial Ownership (4) 08/19/2019 04:02:37 PM
CTSO News: Statement of Changes in Beneficial Ownership (4) 08/16/2019 04:25:08 PM
PostSubject
#17857   Where is everyone??????? stingman49 10/21/19 08:45:35 PM
#17856   Another strong finish.....ZZZZZZZZZZZ fantomphan 10/21/19 04:04:10 PM
#17855   https://www.nature.com/nature/subscribe berthabluefish1 10/19/19 09:51:51 AM
#17854   From Yahoo MB andy55q 10/19/19 09:08:31 AM
#17853   https://www.ncbi.nlm.nih.gov/pubmed/31620999 New PubMed berthabluefish1 10/18/19 07:49:21 AM
#17852   Microcap Presentation:https://cytosorbents.com/wp-content/uploads/2019/10/CytoSo berthabluefish1 10/17/19 05:19:11 PM
#17851   https://www.chicagoreporter.com/infective-endocarditis-a-side-effect-of-the-inje berthabluefish1 10/17/19 11:27:17 AM
#17850   Thanks Hemopure36. stingman49 10/16/19 09:16:27 AM
#17849   One of the reason God gave man opposable orangecat 10/15/19 07:38:31 PM
#17848   A man gets into bed and hands his fantomphan 10/15/19 07:18:31 PM
#17847   One of the best posts ever! hemopure36 10/15/19 07:15:30 PM
#17846   When I finally admitted to my wife that stingman49 10/15/19 05:31:37 PM
#17845   Yes, it was bad from the get go. stingman49 10/15/19 05:02:43 PM
#17844   JUST listen to Dr Chan, my 100th rerun Burnttoast247 10/15/19 03:33:03 PM
#17843   I seem to recall other post CTSO treatment kjpcrna 10/15/19 03:24:43 PM
#17842   Andy, I think this is the first case stingman49 10/15/19 12:58:45 PM
#17841   Thanks everyone for your response. Just couldn't stingman49 10/15/19 09:29:47 AM
#17840   That was a good one Andy. berthabluefish1 10/15/19 08:47:31 AM
#17839   Case of the Week andy55q 10/15/19 08:10:44 AM
#17838   Randomized controlled trial: (RCT) A study in which Burnttoast247 10/15/19 12:19:03 AM
#17837   A randomized controlled trial (or randomized control trial;[2] kjpcrna 10/14/19 08:22:22 PM
#17836   Sorry, Controlled. orangecat 10/14/19 07:03:25 PM
#17835   Randomized Contolled Trial. orangecat 10/14/19 07:02:41 PM
#17834   From Yahoo board. Can someone please tell me stingman49 10/14/19 04:46:20 PM
#17833   I’m not reading anything into Friday’s pop. SP kjpcrna 10/14/19 10:08:36 AM
#17832   Ya, don't remind me! stingman49 10/14/19 09:23:44 AM
#17831   Probably caught up in China market enthusiasm? Maybe Burnttoast247 10/13/19 10:44:36 PM
#17830   Thanks Burnt. I thought it was an stingman49 10/13/19 11:12:38 AM
#17829   I read that when Fre' acquired them, Nx Murph1953 10/12/19 10:30:09 PM
#17828   ?? I can’t find high for day $4.80 Burnttoast247 10/12/19 12:53:39 PM
#17827   Berthabluefish1, You have any idea why the stingman49 10/12/19 12:25:42 PM
#17826   Great post techxen.Good to hear from. berthabluefish1 10/12/19 10:18:48 AM
#17825   Fresenius is focused on developing the critical care techxen 10/12/19 09:41:26 AM
#17824   Murph, "CytoSorbents and its technology has garnered more biotech48 10/11/19 06:04:12 PM
#17823   Their salesforce doubled, but across many territories. Canes16 10/11/19 01:19:23 PM
#17822   Bertha, from your link.. Murph1953 10/11/19 01:13:59 PM
#17821   https://jts.amedd.army.mil/assets/docs/cpgs/JTS_Clinical_Practice_Guidelines_(CP berthabluefish1 10/11/19 11:48:28 AM
#17820   The sales numbers might be better than you firefighter2830 10/11/19 11:38:34 AM
#17819   On 3/1/19 CTSO PPS $8.40 and since been Burnttoast247 10/11/19 09:51:21 AM
#17818   Burnttoast247 10/11/19 09:50:14 AM
#17817   A retrospective analysis of efficacy of hemoadsorption (CytoSorb®) andy55q 10/11/19 09:07:12 AM
#17816   New report shows what non biased shareholders have slappie 10/11/19 08:33:49 AM
#17815   “These potassium binding polymers represent an entirely new biotech48 10/10/19 09:25:44 PM
#17814   $2,959,747, K+ONTROL RENAL SUPPORT SYSTEM FOR REDUCTION OF biotech48 10/10/19 09:24:15 PM
#17813   Someone posted that CTSO IS A DOG WITH Burnttoast247 10/10/19 04:54:23 PM
#17812   Holding support nicely $CTSO Bling Bling1 10/10/19 03:23:44 PM
#17811   I'm still holding shares $CTSO Bling Bling1 10/10/19 03:22:32 PM
#17810   You stated you lost shares. I was just vinovista 10/10/19 02:51:53 PM
#17809   JGR, I wish Dr. Chan would take the Canes16 10/10/19 02:31:18 PM
#17808   Vinnyvista, what kind of stupid question is that? Good Sport 10/10/19 02:10:53 PM
PostSubject
© 2019 InvestorsHub.com, Inc.